Publications
P182
Tetrahedron Lett. 2018, 59, 3519-3523.
Novel approach towards 3,7-disubstituted 1,6-naphthyridin-4(1H)-ones exploiting cross-coupling and SNAr reactions of a dihalogenated compound.
doi: 10.1016/j.tetlet.2018.08.013
P168
X-Ray Struct. Anal. Online 2017, 33, 41-43.
Crystal structure of N-(7-{[2-(dimethylamino)ethyl]amino}-1-methyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-3,4,5-trimethoxybenzamide.
doi: 10.2116/xraystruct.33.41
P156
Eur. J. Med. Chem. 2016, 119, 17-33.
Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90.
doi: 10.1016/j.ejmech.2016.04.050
P141
Tetrahedron 2015, 71, 3303-3313.
Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions.
doi: 10.1016/j.tet.2015.03.110
P140
Mar. Drugs 2015, 13, 4934-48.
The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic Enzymes.
doi: 10.3390/md13084934
P125
Eur. J. Org. Chem. 2014, 7, 1487-1495.
Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings.
P114
ACS Med. Chem. Lett., 2013, 4, 288-292.
Discovery of a novel broad-spectrum antifungal agent, derived from albaconazole.
P113
Eur. J. Med. Chem. 2013, 59, 283-295.
Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.
P112
J. Het. Chem., 2013, 50, 1187-1197.
Efficient new synthesis of N-arylbenzo[b]furo[3,2-d]pyrimidin-4-amines and their benzo[b]thieno[3,2-d]pyrimidin-4-amine analogues via a microwave-assisted Dimroth rearrangement.
P107
Eur. J. Med. Chem., 2012, 58, 171-183.
Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.
P100
Tetrahedron Lett., 2012, 53, 944-947.
First synthesis of 4-aminopyrido[2',3':4,5]furo[3,2-d]pyrimidines.
P96
ChemMedChem, 2011, 6, 1806-1815.
Design, synthesis and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships.
P92
Tetrahedron, 2011, 67, 4767-4773.
A convenient route to functionalized 3-amino-N-methylfuro[3,2-b]pyridine-2-carboxamides.
P91
ChemMedChem, 2011, 6, 816-825.
Design, synthesis and in vitro antifungal activity of 1-[(4-substituted benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
P87
J. Enzym. Inhib. Med. Chem., 2011, 26(2), 261-269.
Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
P86
Bioorg. Med. Chem. Lett., 2010, 20, 5203-5206.
Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities.
P84
Tetrahedron, 2010, 66, 4490-4494.
A convenient route to functionalized 3-amino-6-bromofuro[3,2-b]pyridine-2-carboxamides.
P78
J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.
A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.
P75
Tetrahedron Lett., 2009, 50(41), 5729-5732.
A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination.
P65
J. Enz. Inh. Med. Chem. 2008, 23(5), 629-640.
Design, synthesis and evaluation of new 6-substituted-5-benzyloxy-4-oxo-4H-pyran-2-carboxamides as potential Src inhibitors.
Autres publications scientifiques
Brevets
B12.
Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09114.
B11.
Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09113.
B4.
Nouveaux dérivés de 3-aryl-2,5-dihydroxy-1,4-benzoquinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Fr. Pat. n° 02.01409, 06 Feb. 2002.
Thèse